Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
about
Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance.Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditisAlteration of gentamicin and cefazolin kinetics with control of the hypothyroid state in humans.Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.Therapeutic drug monitoring of aminoglycosides in neonates.Renal consequences of preterm birth.Comparative pharmacokinetics of aminoglycoside antibiotics.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).The amikacin research program: a stepwise approach to validate dosing regimens in neonates.Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditisEffect of low-dose dopamine on the pharmacokinetics of tobramycin in dogs.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidAdverse effects of a single dose of gentamicin in adults: a systematic review.
P2860
Q30479961-9A088DF9-4F1D-45A4-878E-B1EB7E5DC8F6Q34297656-A5C03D29-DBD1-4ECF-9FDA-8F8F2CE2F598Q35023720-66689423-8821-41D3-B6D3-85A9A9EA2F4FQ35131613-49EDE32E-ED2F-4365-82B3-8A383D77D7FAQ35285645-4642B78F-4F4B-4357-BC9E-2017247511ADQ35539207-07E80BCF-0D4D-4A6B-9D77-583AF9F532F9Q35826231-DB6DF73F-20F6-4E7F-9263-1FB63C12042DQ37409465-2652C730-D8C3-4DFC-9F51-DD9E66A9DB85Q37592515-AE4DA865-3081-48A8-8A4C-FE54DF62D23AQ37728154-532CBB2E-CC38-4A9F-8CB0-B796658C7271Q38070006-BBB065B4-477A-43A8-BF8D-23BD78471302Q38821699-FAA08694-F83E-479E-8987-1F01EE031026Q39071799-DBA67ABB-49BC-4ADE-99AF-4025E9CD44A8Q39390126-C0E0CFCC-965B-4E41-9EB7-0DD965893BD7Q39780630-3BDC0E98-AA71-4309-830D-BFDC06F0A92FQ39850813-25A30307-3B1C-4AF6-8B89-BAB2D9316D82Q40600560-1C1E6908-0FE4-40D8-9711-B067DD9C4EB4Q48303892-1889CDE3-86D3-441C-98EA-261FF51E77D1
P2860
Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Renal disposition of gentamici ...... micin, and amikacin in humans.
@ast
Renal disposition of gentamici ...... micin, and amikacin in humans.
@en
type
label
Renal disposition of gentamici ...... micin, and amikacin in humans.
@ast
Renal disposition of gentamici ...... micin, and amikacin in humans.
@en
prefLabel
Renal disposition of gentamici ...... micin, and amikacin in humans.
@ast
Renal disposition of gentamici ...... micin, and amikacin in humans.
@en
P2093
P2860
P356
P1476
Renal disposition of gentamici ...... micin, and amikacin in humans.
@en
P2093
Contrepois A
Delatour F
Deybach JC
Faurisson F
P2860
P304
P356
10.1128/AAC.27.4.520
P407
P577
1985-04-01T00:00:00Z